EQUALY sa.
Biotechnology Research • 
Bruxelles, 1200, Belgium • 1-10 Employees
Company overview
| Headquarters | Bruxelles, 1200, Belgium |
| Website | |
| Employees | 1-10 |
| Socials |
Key Contact at EQUALY sa.
Jean-Marie Saint-Remy
Founder - Cso
About EQUALY sa.
Equaly is a discovery-stage biotechnology company, dedicated to leverage the role of a newly discovered type of Natural Killer T (“NKT”) cells to propose an innovative immunological approach to fight and eliminate tumour cells. Based on a newly discovered population of NKT lymphocytes, that can be activated by specific antigen through the same mechanism for everyone, allowing allogenic applications, Equaly develops innovative therapies that have the potential to revolutionise the treatment of cancers by offering a safer, more effective, and more affordable option than current therapies. Using the dynamic of the very same NKT cells, Equaly also develops non-immunogenic versions of existing Enzyme Replacement Therapies against metabolic orphan diseases.
EQUALY sa. revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
EQUALY sa. has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
EQUALY sa. has never raised funding before.
EQUALY sa. Tech Stack
Discover the technologies and tools that power EQUALY sa.'s digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Analytics
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
Font scripts
United States
Australia
Frequently asked questions
4.8
40,000 users
